CHURCHILL MANAGEMENT Corp Has $11.73 Million Holdings in Danaher Co. (NYSE:DHR)

CHURCHILL MANAGEMENT Corp raised its stake in Danaher Co. (NYSE:DHR - Free Report) by 2.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 51,111 shares of the conglomerate's stock after buying an additional 1,460 shares during the quarter. CHURCHILL MANAGEMENT Corp's holdings in Danaher were worth $11,732,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DHR. FMR LLC grew its holdings in shares of Danaher by 15.8% in the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate's stock valued at $6,566,116,000 after buying an additional 3,217,631 shares during the period. Massachusetts Financial Services Co. MA lifted its holdings in Danaher by 17.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate's stock worth $996,141,000 after acquiring an additional 535,254 shares in the last quarter. International Assets Investment Management LLC grew its stake in Danaher by 40,196.5% in the third quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate's stock valued at $119,539,000 after acquiring an additional 428,897 shares during the period. Montrusco Bolton Investments Inc. increased its holdings in shares of Danaher by 30.4% in the third quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate's stock worth $465,617,000 after acquiring an additional 397,671 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec raised its position in shares of Danaher by 82.4% during the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 653,375 shares of the conglomerate's stock worth $181,651,000 after purchasing an additional 295,187 shares during the period. Institutional investors own 79.05% of the company's stock.

Wall Street Analyst Weigh In

DHR has been the subject of a number of research reports. Evercore ISI increased their target price on Danaher from $275.00 to $278.00 and gave the stock an "outperform" rating in a research note on Tuesday, October 1st. Stephens reissued an "overweight" rating and set a $315.00 price objective on shares of Danaher in a research report on Wednesday, October 23rd. Citigroup cut their price objective on shares of Danaher from $305.00 to $285.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Barclays lowered their target price on Danaher from $285.00 to $275.00 and set an "equal weight" rating for the company in a report on Wednesday, October 23rd. Finally, Bank of America upgraded Danaher from a "neutral" rating to a "buy" rating and set a $290.00 price target on the stock in a report on Friday, December 13th. Six equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $286.80.

Danaher Stock Performance

Shares of DHR traded up $3.97 during midday trading on Thursday, reaching $241.94. The stock had a trading volume of 3,148,897 shares, compared to its average volume of 3,191,500. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The firm has a 50 day simple moving average of $235.07 and a 200-day simple moving average of $253.45. The firm has a market cap of $174.75 billion, a PE ratio of 46.17, a P/E/G ratio of 4.23 and a beta of 0.83. Danaher Co. has a one year low of $222.53 and a one year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same quarter in the prior year, the company earned $2.02 earnings per share. The business's revenue for the quarter was up 3.1% compared to the same quarter last year. As a group, sell-side analysts anticipate that Danaher Co. will post 7.49 EPS for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be given a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. Danaher's dividend payout ratio (DPR) is 20.61%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.